<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">Hindawi Publishing Corporation</span>
         <h2 class="citation-title">Synaptosomal Protein of 25 kDa (Snap25) Polymorphisms Associated with Glycemic Parameters
            in Type 2 Diabetes Patients
         </h2>
         <span class="doi">10.1155/2016/8943092</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Nasser M. Al-Daghri</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Andrea S. Costa</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Majed S. Alokail</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Milena Zanzottera</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Amal M. Alenad</span>
            <span class="citation_author_institution_ref">4</span>
            <span class="citation_author">Abdul Khader Mohammed</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Mario Clerici</span>
            <span class="citation_author_institution_ref">3</span>
            <span class="citation_author">Franca R. Guerini</span>
            <span class="citation_author_institution_ref">3</span>
         </div>
         <span class="email">[aldaghri2011@gmail.com]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2015-12-8]</span>
         <span class="citation_copyright">[Copyright 2016: ]</span>
         <span class="citation_licence">[Licence This is an open access article distributed under the Creative Commons Attribution
            License, which permits unrestricted use, distribution, and reproduction in any medium,
            provided the original work is properly cited.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>A possible role of
            <i> Snap25</i> polymorphisms in type 2 diabetes mellitus (T2DM) was evaluated by analyzing three
            SNPs within intron 1 in a region known to affect the gene expression in vitro. Genomic
            DNA from 1019 Saudi individuals (489 confirmed T2DM and 530 controls) was genotyped
            for SNPs rs363039, rs363043, and rs363050 in
            <i> Snap25</i> using the TaqMan Genotyping Assay. Significantly higher levels of fasting glucose
            and HbA1c were detected in T2DM patients carrying the rs363050 (AG/GG) genotypes compared
            to the (AA) genotype (
            <i>f</i> = 4.41, 
            <i>df</i> = 1, and 
            <i>p</i> = 0.03 and 
            <i>f</i> = 5.31, 
            <i>df</i> = 1, and 
            <i>p</i> = 0.03, resp.). In these same patients, insulin levels were significantly decreased
            compared to the (AA) individuals (
            <i>f</i> = 7.29, 
            <i>df</i> = 1, and 
            <i>p</i> = 0.009). Significant associations were detected between rs363050 (AG/GG) genotypes
            and increasing fasting glucose levels (
            <i>p</i> = 0.01 and OR: 1.05), HbA1c levels (OR: 5.06 and 
            <i>p</i> = 0.02), and lower insulinemia (
            <i>p</i> = 0.03 and OR: 0.95) in T2DM patients. The minor
            <i> Snap25</i> rs363050 (G) allele, which results in a reduced expression of
            <i> Snap25</i>, is associated with altered glycemic parameters in T2DM possibly because of reduced
            functionality in the exocytotic machinery leading to suboptimal release of insulin.
         </p>
      </div>
      <div tagxxx="sec">
         <title>1. Introduction</title>
         <p>Blood glucose levels are regulated by insulin release from pancreatic 
            <i>β</i>-cells via exocytosis, a fine-tuned mechanism mediated by complex machinery. During
            the exocytotic process secretory granules (SG) of insulin fuse with the plasma membrane;
            this process is mediated by a number of key players including the soluble
            <i> N</i>-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins. The
            SNARE-complex includes the two t-SNARE proteins, synaptosomal protein of 25 kDa (Snap25)
            and syntaxin 1A, as well as the v-SNARE protein VAMP2. To allow exocytosis the amino
            terminal of Snap25 binds to syntaxin 1A and the carboxy-terminal binds to VAMP2, forming
            the four-helical bundle that brings SG in close contact with the plasma membrane,
            thus enabling fusion to occur. Snap25 is contained in insulin-secreting cells [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">1</a>
               </sup>
            </span>] and is known to modulate several processes apart from the actual fusion event, including
            the activity of potassium voltage gated (Kv)2.1 channels [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>]. Notably, Kv2.1 is the prevalent Kv channel in neuroendocrine and endocrine cells,
            and the Kv2.1 current repolarizes 
            <i>β</i>-cell action potentials upon exposure to glucose to limit Ca
            <sup>2+</sup> entry and insulin secretion.
         </p>
         <p>Because of the pivotal role of Snap25 in insulin release [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">6</a>
               </sup>
            </span>] we evaluated a possible role of three
            <i> Snap25</i> polymorphisms (rs363039, rs363043, and rs363050) that are localized within intron
            1 in a region spanning about 13.8 kb and are known to affect the gene expression in
            vitro [
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">7</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">8</a>
               </sup>
            </span>], in type 2 diabetes mellitus (T2DM). To this end, fasting glycemia, insulinemia,
            and the concentration of glycated haemoglobin (HbA1c) were correlated with
            <i> Snap25</i> polymorphisms in 489 patients with a diagnosis of type 2 diabetes mellitus (T2DM)
            and 530 age- and sex-matched healthy controls (HC).
         </p>
      </div>
      <div tagxxx="sec">
         <title>2. Methods</title>
         <div tagxxx="sec">
            <h3>2.1. Patients and Controls</h3>
            <p>A total of 1019 unrelated adult Saudi individuals (489 confirmed T2DM (280 males and
               209 females) and 530 controls (319 males and 211 females)) were randomly selected
               from the Biomarker Screening Project in Riyadh (Riyadh Cohort), a capital-wide epidemiological
               study of over 17,000 consenting Saudis coming from different Primary Health Care Centers
               (PHCCs) in Kingdom of Saudi Arabia (KSA). Written informed consent was obtained from
               all participants before inclusion in the study. The research was approved by the Ethics
               Committee of the College of Science, King Saud University, Riyadh, KSA, and the methods
               were carried out in accordance with the approved guidelines. Diagnosis of T2DM was
               based on World Health Organization (WHO) proposed cut-off: fasting plasma glucose
               &gt; or = 7.0 mmol/L or 126 mg/dL. Subjects with comorbidities that needed medical attention
               or with medical complications (coronary artery disease, nephropathy, thyroid diseases,
               and end stage renal or liver disease) were excluded from the study. Consenting participants
               were then requested to visit the nearest participating PHCC for questionnaire administration,
               anthropometric measurement, and blood extraction. A questionnaire focusing on demographic
               information and past and present medical history was given to all subjects.
            </p>
         </div>
         <div tagxxx="sec">
            <h3>2.2. Anthropometry, Blood Collection, and Biochemical Analyses</h3>
            <p>Subjects were requested to visit their respective PHCCs following overnight fasting
               (&gt;10 hours) for anthropometry and blood withdrawal. Anthropometry included height
               (rounded off to the nearest 0.5 cm), weight (rounded off to the nearest 0.1 kg), waist
               and hip circumference (centimeters), and mean systolic and diastolic blood pressure
               (millimeters of Hg) (average of 2 readings). Body mass index (BMI) was calculated
               as weight in kilograms divided by height in square meters. Fasting glucose and lipid
               profile were measured using a chemical analyzer (Konelab, Espoo, Finland). Serum insulin
               was assessed using an enzyme-linked immunosorbent assay (ELISA) with an intra-assay
               variability of &lt;10% and interassay variation of &lt;15%. All fasting samples fell within
               the detection range.
            </p>
         </div>
         <div tagxxx="sec">
            <h3>2.3.
               
               <i>Snap25 </i>Genotyping
            </h3>
            <p>Genomic DNA was isolated from whole blood using the blood genomicPrep mini spin kit
               (GE Healthcare Life Sciences, Piscataway, NJ, USA). SNPs rs363043, rs363039, and rs363050
               located in intron 1 of
               <i> Snap25</i> gene were genotyped using the TaqMan SNP Genotyping Assays (Applied Biosystems by
               Life Technologies, Foster City, CA, USA) on an ABI PRISM 7000 Sequence Detection System.
            </p>
         </div>
         <div tagxxx="sec">
            <h3>2.4. Statistical Analysis</h3>
            <p>The Kolmogorov-Smirnov (K-S) test was applied to verify normal distribution of numerical
               variable scores. All numerical scores resulted in being normally distributed, and
               they were shown as mean and standard deviation (SD). Hardy-Weinberg equilibrium was
               tested using Chi-square test. ANOVA calculation was performed to analyse biochemical
               parameters in relationship with
               <i> Snap25</i> genotypes stratified for T2DM and HC. Moreover multivariate stepwise logistic regression
               analysis was performed, using
               <i> Snap25</i> polymorphisms as responsible variables and age, gender, and BMI as covariates.
            </p>
         </div>
      </div>
      <div tagxxx="sec">
         <title>3. Results and Discussion</title>
         <p>Fasting glycemia, insulinemia, and the concentration of glycated haemoglobin (HbA1c)
            were correlated with
            <i> Snap25</i> polymorphisms in 489 patients with a diagnosis of T2DM and 530 age- and sex-matched
            HC (
            <span ref-type="table" rid="tab1">
               <a href="#tab1">Table 1</a>
            </span>), whereas no differences were seen in the distribution of the 3
            <i> Snap25</i> SNPs between T2DM and controls (data not shown). Significantly higher levels of fasting
            glucose and HbA1c were detected in T2DM patients carrying the rs363050 (AG/GG) (57%
            of cases) genotypes compared to those carrying the (AA) genotype (43% of cases) (
            <i>f</i> = 4.41, 
            <i>df</i> = 1, and 
            <i>p</i> = 0.03 and 
            <i>f</i> = 5.31, 
            <i>df</i> = 1, and 
            <i>p</i> = 0.03, resp.). In these same patients insulin levels were significantly decreased
            as well compared to the (AA) individuals (
            <i>f</i> = 7.29,  
            <i>df</i> = 1, and 
            <i>p</i> = 0.009) (
            <span ref-type="table" rid="tab2">
               <a href="#tab2">Table 2</a>
            </span>). In contrast with these results, no associations were observed between any of the
            <i> Snap25</i> genotypes and glycemic parameters in HC (
            <i>f</i> = 0.88,  
            <i>df</i> = 1, and 
            <i>p</i> = 0.35).
         </p>
         <p>The correlation between the rs363050 (G) minor allele and altered glycemic parameters
            in T2DM patients was even stronger when multivariate stepwise logistic regression
            analysis was performed. Thus, when rs363050 (AG/GG) versus (AA) was calculated as
            the responsible variable and age, gender, and BMI were calculated as covariates, a
            statistically significant association was detected between (AG/GG) genotypes and increasing
            fasting glucose levels (
            <i>p</i> = 0.01, OR: 1.05), with a higher risk in female versus male patients (
            <i>p</i> = 0.03, OR: 1.63). A similar association was observed as well between the (AG/GG)
            genotypes and increasing HbA1c levels (
            <i>p</i> = 0.02, OR: 5.06) and between these genotypes and lower insulinemia (
            <i>p</i> = 0.03, OR: 0.95) in T2DM patients after adjustment for BMI, gender, and age covariates,
            even if in this case no specific risk was detected in female patients. Again, no such
            associations were observed in healthy controls. To rule out a possible role played
            by confounding factors, diabetes duration, hypoglycemic drug use, insulin resistance
            condition, and anthropometric parameters were compared between patients carrying the
            two genotypes, and no significant differences emerged (data not shown).
         </p>
         <p>Insulin secretion depends on the integrity of the SNARE exocytotic machinery, as shown
            by the observation that decreased expression of t-SNARE associates with an alteration
            of this process [
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">5</a>
               </sup>
            </span>].  Snap25, a protein that is expressed in pancreatic endocrine cells, is an essential
            component of such machinery [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">4</a>
               </sup>
            </span>]. Data herein shows that the
            <i> Snap25</i> rs363050 (G) allele correlates with increasing glycemia and HbA1c concentration,
            as well as with reduced insulinemia in T2DM patients alone; this allele was recently
            demonstrated to be associated with a significantly reduced gene expression in vitro
            compared to the rs363050 (A) allele [
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">8</a>
               </sup>
            </span>]. Because no associations between glycemic parameters and
            <i> Snap25</i> polymorphism were detected in healthy controls this polymorphism is not likely to
            be a genetic risk factor for T2DM by itself but rather to correlate with altered T2DM-related
            metabolic parameters once T2DM has been diagnosed. This effect is possibly mediated
            by impairment in the SNARE complex, resulting in a reduced functionality of the exocytotic
            machinery and, as a consequence, in a suboptimal release of insulin.
         </p>
      </div>
      <div tagxxx="sec">
         <title>4. Conclusions</title>
         <p>Snap25 plays an important role in exocytosis, and its polymorphisms have been implicated
            in modulating the release of neurotransmitters in a number of neurologic conditions
            including autism and Alzheimer's disease (AD) [
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">9</a>
               </sup>
            </span>]. Importantly, the integrity of the insulin signaling plays a pivotal role for cognitive
            function and memory. Thus, in neurons, insulin stimulates growth, survival, differentiation,
            metabolism, protein synthesis, synapse formation, and plasticity [
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">10</a>
               </sup>
            </span>]. The preliminary results herein indicate that the same
            <i> Snap25</i> SNPs are present in AD and in T2DM; these data add further evidence to the importance
            played by an intact insulin signaling pathway in the maintenance of well-structured
            cognitive functions and reinforce the idea that
            <i> Snap25</i> polymorphisms play a role in metabolic disorders. Notably, polymorphisms in the human
            <i> Snap25</i> gene have been associated with weight gain after antipsychotic treatment and with
            altered levels of serum triglycerides [
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">11</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">12</a>
               </sup>
            </span>] and, importantly, with the severity of metabolic syndrome in T2DM [
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">13</a>
               </sup>
            </span>] These data, finally, confirm previous results showing a role of Snap25 in insulin
            secretion [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">2</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">6</a>
               </sup>
            </span>]. Because the incidence of AD is increased in T2DM [
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">14</a>
               </sup>
            </span>] it will be interesting to explore whether
            <i> Snap25</i> alleles-mediated exocytosis alterations bridge these two pathologies, possibly predicting
            those T2DM patients with a higher risk of developing AD.
         </p>
      </div>
      <back>
         <div tagxxx="ack">
            <title>Acknowledgments</title>
            <p>The authors thank the Deanship of Scientific Research, Prolific Research Group Program
               (PRG-1436-15), Vice Rectorate for Graduate Studies, and Scientific Research in King
               Saud University (KSU), Riyadh, Saudi Arabia, for funding the study.
            </p>
         </div>
         <div tagxxx="sec">
            <title>Conflict of Interests</title>
            <p>The authors have no conflict of interests to declare. The authors have no financial
               and nonfinancial conflict of interests.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B1"></a>
                  <label>1</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Vikman</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Svensson</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">Y.-C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Truncation of SNAP-25 reduces the stimulatory action of cAMP on rapid exocytosis in
                        insulin-secreting cells
                     </span>
                     <span tagx="source">
                        <i>The American Journal of Physiology—Endocrinology and Metabolism</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">297</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">E452</span>
                     <span tagx="lpage">E461</span>
                     <span class="pub-id'">[10.1152/ajpendo.90585.2008]</span>
                     <span class="pub-id'">[2-s2.0-68049096966]</span>
                     <span class="pub-id'">[19509185]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <label>2</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">MacDonald</span>
                           <span tagx="given-names">P. E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tsuk</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Synaptosome-associated protein of 25 kilodaltons modulates Kv2.1 Voltage-dependent
                        K
                        <sup>+</sup> channels in neuroendocrine islet 
                        <i>β</i>-cells through an interaction with the channel N terminus
                     </span>
                     <span tagx="source">
                        <i>Molecular Endocrinology</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">16</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">2452</span>
                     <span tagx="lpage">2461</span>
                     <span class="pub-id'">[10.1210/me.2002-0058]</span>
                     <span class="pub-id'">[2-s2.0-0036843905]</span>
                     <span class="pub-id'">[12403834]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <label>3</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Sadoul</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lang</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Montecucco</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">SNAP-25 is expressed in islets of Langerhans and is involved in insulin release</span>
                     <span tagx="source">
                        <i>Journal of Cell Biology</i>
                     </span>
                     <span tagx="year">1995</span>
                     <span tagx="volume">128</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">1019</span>
                     <span tagx="lpage">1028</span>
                     <span class="pub-id'">[10.1083/jcb.128.6.1019]</span>
                     <span class="pub-id'">[2-s2.0-0028940786]</span>
                     <span class="pub-id'">[7896868]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <label>4</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gonelle-Gispert</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Halban</span>
                           <span tagx="given-names">P. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Niemann</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Palmer</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Catsicas</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sadoul</span>
                           <span tagx="given-names">K.</span>
                        </name>
                     </span>
                     <span tagx="article-title">SNAP-25a and -25b isoforms are both expressed in insulin-secreting cells and can function
                        in insulin secretion
                     </span>
                     <span tagx="source">
                        <i>Biochemical Journal</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">339</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">159</span>
                     <span tagx="lpage">165</span>
                     <span class="pub-id'">[10.1042/bj3390159]</span>
                     <span class="pub-id'">[10085240]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <label>5</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Nagamatsu</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Nakamichi</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Yamamura</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic 
                        <i>β</i>-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration
                        of decreased t-SNARE proteins improves impaired insulin secretion
                     </span>
                     <span tagx="source">
                        <i>Diabetes</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">48</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">2367</span>
                     <span tagx="lpage">2373</span>
                     <span class="pub-id'">[10.2337/diabetes.48.12.2367]</span>
                     <span class="pub-id'">[2-s2.0-0033513495]</span>
                     <span class="pub-id'">[10580425]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <label>6</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Zhuang</span>
                           <span tagx="given-names">G.-Q.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wu</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Liu</span>
                           <span tagx="given-names">F.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">SNAP-25
                        <sub>1-180</sub> enhances insulin secretion by blocking Kv2.1 channels in rat pancreatic islet 
                        <i>β</i>-cells
                     </span>
                     <span tagx="source">
                        <i>Biochemical and Biophysical Research Communications</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">379</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">812</span>
                     <span tagx="lpage">816</span>
                     <span class="pub-id'">[10.1016/j.bbrc.2008.12.059]</span>
                     <span class="pub-id'">[2-s2.0-59249088421]</span>
                     <span class="pub-id'">[19103161]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <label>7</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gosso</span>
                           <span tagx="given-names">M. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">De Geus</span>
                           <span tagx="given-names">E. J. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Polderman</span>
                           <span tagx="given-names">T. J. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Boomsma</span>
                           <span tagx="given-names">D. I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Heutink</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Posthuma</span>
                           <span tagx="given-names">D.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Common variants underlying cognitive ability: further evidence for association between
                        the SNAP-25 gene and cognition using a family-based study in two independent Dutch
                        cohorts
                     </span>
                     <span tagx="source">
                        <i>Genes, Brain and Behavior</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">355</span>
                     <span tagx="lpage">364</span>
                     <span class="pub-id'">[10.1111/j.1601-183x.2007.00359.x]</span>
                     <span class="pub-id'">[2-s2.0-41749097207]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <label>8</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Braida</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Guerini</span>
                           <span tagx="given-names">F. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Ponzoni</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Association between SNAP-25 gene polymorphisms and cognition in autism: functional
                        consequences and potential therapeutic strategies
                     </span>
                     <span tagx="source">
                        <i>Translational Psychiatry</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">1, article e500</div>
                     <span class="pub-id'">[10.1038/tp.2014.136]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <label>9</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Guerini</span>
                           <span tagx="given-names">F. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Agliardi</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sironi</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Possible association between SNAP-25 single nucleotide polymorphisms and alterations
                        of categorical fluency and functional MRI parameters in Alzheimer's disease
                     </span>
                     <span tagx="source">
                        <i>Journal of Alzheimer's Disease</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">42</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">1015</span>
                     <span tagx="lpage">1028</span>
                     <span class="pub-id'">[10.3233/jad-140057]</span>
                     <span class="pub-id'">[2-s2.0-84907143536]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <label>10</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">de la Monte</span>
                           <span tagx="given-names">S. M.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease</span>
                     <span tagx="source">
                        <i>Current Alzheimer Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">9</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">35</span>
                     <span tagx="lpage">66</span>
                     <span class="pub-id'">[10.2174/156720512799015037]</span>
                     <span class="pub-id'">[2-s2.0-84856496197]</span>
                     <span class="pub-id'">[22329651]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <label>11</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Müller</span>
                           <span tagx="given-names">D. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Klempan</span>
                           <span tagx="given-names">T. A.</span>
                        </name>
                        <name>
                           <span tagx="surname">De Luca</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic
                        treatment of schizophrenia
                     </span>
                     <span tagx="source">
                        <i>Neuroscience Letters</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">379</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">81</span>
                     <span tagx="lpage">89</span>
                     <span class="pub-id'">[10.1016/j.neulet.2004.12.037]</span>
                     <span class="pub-id'">[2-s2.0-20144388485]</span>
                     <span class="pub-id'">[15823421]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <label>12</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Musil</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Spellmann</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Riedel</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">SNAP-25 gene polymorphisms and weight gain in schizophrenic patients</span>
                     <span tagx="source">
                        <i>Journal of Psychiatric Research</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">42</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">963</span>
                     <span tagx="lpage">970</span>
                     <span class="pub-id'">[10.1016/j.jpsychires.2007.11.003]</span>
                     <span class="pub-id'">[2-s2.0-49149108655]</span>
                     <span class="pub-id'">[18191416]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <label>13</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Chen</span>
                           <span tagx="given-names">Y. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pei</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hung</span>
                           <span tagx="given-names">Y. J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Associations between genetic variants and the severity of metabolic syndrome in subjects
                        with type 2 diabetes
                     </span>
                     <span tagx="source">
                        <i>Genetics and Molecular Research</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">14</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">2518</span>
                     <span tagx="lpage">2526</span>
                     <span class="pub-id'">[10.4238/2015.march.30.10]</span>
                     <span class="pub-id'">[25867398]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <label>14</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kopf</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Frölich</span>
                           <span tagx="given-names">L.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Risk of incident Alzheimer's disease in diabetic patients: a systematic review of
                        prospective trials
                     </span>
                     <span tagx="source">
                        <i>Journal of Alzheimer's Disease</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">16</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">677</span>
                     <span tagx="lpage">685</span>
                     <span class="pub-id'">[10.3233/jad-2009-1011]</span>
                     <span class="pub-id'">[2-s2.0-67649742213]</span>
                  </span>
               </li>
            </ul>
         </div>
      </back>
      <div tagxxx="floats-group">
         <div id="tab1">
            <label>Table 1</label>
            <caption>
               <p>Clinical characteristic of the T2DM patients and the healthy controls enrolled in
                  the study.
               </p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th> </th>
                     <th>Healthy controls</th>
                     <th>T2DM</th>
                  </tr>
                  <tr>
                     <th>
                        <i>N</i>
                     </th>
                     <th>530</th>
                     <th>489</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Gender male/female</td>
                     <td>319/211</td>
                     <td>280/209</td>
                  </tr>
                  <tr>
                     <td>Age (years)</td>
                     <td>48.5 ± 12.5</td>
                     <td>51.2 ± 11.5</td>
                  </tr>
                  <tr>
                     <td>Systolic BP (mmHg)</td>
                     <td>117.6 ± 12.3</td>
                     <td>129.7 ± 15.1
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Diastolic BP (mmHg)</td>
                     <td>75.7 ± 8.4</td>
                     <td>80.7 ± 8.9
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>BMI (kg/m
                        <sup>2</sup>)
                     </td>
                     <td>28.8 ± 7.4</td>
                     <td>32.0 ± 5.9
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Hip circumference (cm)</td>
                     <td>87.1 ± 22.0</td>
                     <td>98.0 ± 24.2
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Waist circumference (cm)</td>
                     <td>98.5 ± 25.0</td>
                     <td>103.0 ± 26.9
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Total cholesterol (mmol/L)</td>
                     <td>5.1 ± 1.0</td>
                     <td>5.3 ± 1.2
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Fasting glucose (mmol/L)</td>
                     <td>5.1 ± 0.9</td>
                     <td>12.0 ± 4.7</td>
                  </tr>
                  <tr>
                     <td>HbA1c (IU)</td>
                     <td>5.2 ± 0.5</td>
                     <td>7.5 ± 1.3
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Insulinemia 
                        <i>µ</i>U/mL
                     </td>
                     <td>11.2 ± 18.2</td>
                     <td>18.4 ± 17.7
                        <sup>
                           <i>∗∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>LDL-cholesterol (mmol/L)</td>
                     <td>3.4 ± 0.9</td>
                     <td>3.5 ± 1.0</td>
                  </tr>
                  <tr>
                     <td>HDL-cholesterol (mmol/L)</td>
                     <td>0.9 ± 0.4</td>
                     <td>0.8 ± 0.3
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Triglycerides (mmol/L)</td>
                     <td>1.5 ± 0.8</td>
                     <td>2.2 ± 1.3
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <fn>
                  <p>Median values ± standard deviation (SD) are shown. Statistically significant differences
                     are indicated: 
                     <sup>
                        <i>∗</i>
                     </sup>
                     <i>p</i> &lt; 0.001; 
                     <sup>
                        <i>∗∗</i>
                     </sup>
                     <i>p</i> &lt; 0.05.
                  </p>
               </fn>
            </table-wrap-foot>
         </div>
         <div id="tab2">
            <label>Table 2</label>
            <caption>
               <p>Glycemic parameters in 489 T2DM patients according to the 
                  <i>Snap25</i> rs36305 genotype.
               </p>
            </caption>
            <table>
               <thead>
                  <tr>
                     <th> </th>
                     <th>
                        <i>Snap25</i> rs363050 genotype
                        <div tagxxx="break"></div>
                     </th>
                  </tr>
                  <tr>
                     <th> </th>
                     <th>AA</th>
                     <th>AG + GG</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td>Fasting glucose (mmol/L)</td>
                     <td>11.5 ± 4.3
                        <sup>
                           <i>∗∗</i>
                        </sup>
                     </td>
                     <td>12.9 ± 4.9
                        <sup>
                           <i>∗∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>HbA1c (IU)</td>
                     <td>6.9 ± 0.9
                        <sup>
                           <i>∗∗</i>
                        </sup>
                     </td>
                     <td>8.2 ± 1.4
                        <sup>
                           <i>∗∗</i>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td>Insulinemia 
                        <i>µ</i>U/mL
                     </td>
                     <td>23.9 ± 23.1
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                     <td>13.4 ± 8.1
                        <sup>
                           <i>∗</i>
                        </sup>
                     </td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <fn>
                  <p>Median values ± standard deviation (SD) are shown. Statistically significant differences
                     are indicated: 
                     <sup>
                        <i>∗</i>
                     </sup>
                     <i>p</i> &lt; 0.001; 
                     <sup>
                        <i>∗∗</i>
                     </sup>
                     <i>p</i> &lt; 0.05.
                  </p>
               </fn>
            </table-wrap-foot>
         </div>
      </div>
   </article>
</html>